awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41694135-1006273C-F84B-4DF9-9ED6-4226C4CF4EAD
Q41694135-1006273C-F84B-4DF9-9ED6-4226C4CF4EAD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41694135-1006273C-F84B-4DF9-9ED6-4226C4CF4EAD
Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets
P2860
Q41694135-1006273C-F84B-4DF9-9ED6-4226C4CF4EAD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41694135-1006273C-F84B-4DF9-9ED6-4226C4CF4EAD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b3bc7a723c489e6074a3120861efbc3774291b5d
P2860
Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.